Indirect comparison of continuous and time‑limited BTKi-venetoclax in TP53‑wild‑type CLL: does IGHV still matter?
Related Experiment Video
Updated: Mar 6, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.7K
Stefano Molica1, Diana Giannarelli2, David Allsup1,3
1Hull York Medical School, University of Hull, Hull, United Kingdom.
Leukemia & Lymphoma
|March 4, 2026
Abstract
No abstract available in PubMed .

